CCL3L1 and HIV/AIDS susceptibility.
Urban
Thomas J
TJ
Weintrob
Amy C
AC
Fellay
Jacques
J
Colombo
Sara
S
Shianna
Kevin V
KV
Gumbs
Curtis
C
Rotger
Margalida
M
Pelak
Kimberly
K
Dang
Kristen K
KK
Detels
Roger
R
Martinson
Jeremy J
JJ
O'Brien
Stephen J
SJ
Letvin
Norman L
NL
McMichael
Andrew J
AJ
Haynes
Barton F
BF
Carrington
Mary
M
Telenti
Amalio
A
Michael
Nelson L
NL
Goldstein
David B
DB
D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics*; D000349:Africa / Q000453:epidemiology; D016022:Case-Control Studies; D019742:Chemokines, CC / Q000235:genetics* / Q000378:metabolism; D015331:Cohort Studies; D018450:Disease Progression; D005006:Ethnicity / Q000235:genetics; D005060:Europe / Q000453:epidemiology; D005260:Female; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D014644:Genetic Variation; D005838:Genotype; D015658:HIV Infections / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008297:Male; D012333:RNA, Messenger / Q000378:metabolism; D044469:Racial Groups / Q000235:genetics; D019713:Receptors, CCR5 / Q000378:metabolism; D012307:Risk Factors; D016019:Survival Analysis; D019562:Viral Load
C492767:CCL3L1 protein, human; D019742:Chemokines, CC; D008024:Ligands; D012333:RNA, Messenger; D019713:Receptors, CCR5